Amazon Web Services (AWS) launched Amazon Bio Discovery to accelerate early-stage drug research. The AI-powered application allows scientists to execute complex computational workflows without coding. This platform can potentially reduce research timelines from months to weeks. Early adopters of the technology include Bayer and Voyager Therapeutics.
GSK completed its $950 million acquisition of Canadian biopharmaceutical firm 35Pharma. The deal secures a promising molecule for treating pulmonary hypertension. A consortium raised its takeover bid for Australian fertility provider Monash IVF to $311 million. Johnson & Johnson announced its 64th consecutive annual dividend increase.